- Pfizer-BioNTech is approved for people 5 years and older.
- Moderna is approved for people 18 years and older.
- Johnson & Johnson is approved for people 18 years and older.
FDA and CDC have now recommended the Pfizer-BioNTech Covid-19 vaccine for children ages 5-11.
- Adolescents ages 12 years and older receive the same dosage of Pfizer-BioNTech Covid-19 Vaccine as adults.
- Children ages 5 through 11 years receive one-third of the adult dose of Pfizer-BioNTech COVID-19 Vaccine. Smaller needles, designed specifically for children, are used for children ages 5 through11 years.
- COVID-19 vaccine dosage does not vary by patient weight but by age on the day of vaccination.
- Your child will need a second shot of the Pfizer-BioNTech Covid-19 vaccine three weeks after their first shot.
During May 2021, both the FDA and CDC have recommended the Pfizer-BioNTech vaccine for children aged 12-15. More recently, in late October/early November, both the FDA and CDC have expanded their recommendation to include children 5 years and older.
PfizerBioNTech began testing its vaccine in children (from 6 months old to 11 years old) in late March.
Moderna is also conducting a trial in children 12 years and older.
It is also conducting a study (KidsCove) to test the vaccine on children 6 months to less than 12 years old. Moderna plans to enroll approximately 6,750 pediatric participants in the U.S. and Canada in the two-part study.
Updated: November 4, 2021